Technological challenges for future probiotic foods

Abstract Modern consumers are increasingly interested in their personal health, and expect the food that they eat to be healthy or even capable of preventing illness. Gut health in general has shown to be the key sector for functional foods in Europe. The probiotic yoghurt market is well established but the key growth sector recently has been the probiotic drinks. The popularity of dose-delivery systems for probiotic drinks has also resulted in research efforts targeted to developing probiotic foods outside the dairy sector. New product categories, and thus novel and more difficult raw materials with regard to technology of probiotics, will certainly be the key research and development area for future functional food markets. The viability and stability of probiotics has been both a marketing and technological challenge for industrial producers. Probiotic foods should contain specific probiotic strains and maintain a suitable level of viable cells during the product's shelf life. Unless strict demands are set on probiotic product definition and labelling their regulatory definition will remain obscure. The technological demands placed on probiotic strains are great and new manufacturing process and formulation technologies may often be required for bacteria primarily selected for their functional health properties. Before probiotic strains can be delivered to consumers, they must first be able to be manufactured under industrial conditions, and then survive and retain their functionality during storage as frozen or freeze-dried cultures, and also in the food products into which they are finally formulated. The probiotic strains should also survive the gastrointestinal stress factors and maintain their functionality within the host. Additionally, they must be able to be incorporated into foods without producing off-flavours or textures—they should be viable but not growing. The packaging materials used and the conditions under which the products are stored are also important for the quality of products. Future technological prospects exist in innovations finding solutions for the stability and viability problems of probiotics in new food environments. Current research on novel probiotic formulations and microencapsulation technologies exploiting biological carrier and barrier materials and systems for enteric release provides promising results. Maintenance of low production costs will remain the challenge for future probiotic process and formulation technologies. Exploitation of food-grade raw materials such as native, and physically or enzymatically treated starches, is one example of future technology that has the potential to meet the challenge of broadening the range of food types into which probiotic ingredients can be successfully incorporated. Novel developments for control release systems in foods and pharmaceuticals will also provide new possibilities.

[1]  H. Elzinga,et al.  Digestion of so-called resistant starch sources in the human small intestine. , 2000, The American journal of clinical nutrition.

[2]  S. Salminen,et al.  The Health Effects of Cultured Milk Products with Viable and Non-viable Bacteria , 1998 .

[3]  G. Tannock Probiotics A critical review , 1999 .

[4]  B. Wood,et al.  Microbiology of Fermented Foods , 1997, Springer US.

[5]  H. Blottière,et al.  Enhancement of butyrate production in the rat caecocolonic tract by long-term ingestion of resistant potato starch , 1999, British Journal of Nutrition.

[6]  G R Gibson,et al.  Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. , 1995, The Journal of nutrition.

[7]  T. Mattila-Sandholm,et al.  Lactic acid bacteria with health claims—interactions and interference with gastrointestinal flora , 1999 .

[8]  T. Mitsuoka,et al.  Effect of Follow-Up Formula Containing Bifidobacteria (NAN BF) on Fecal Flora and Fecal Metabolites in Healthy Children , 1997 .

[9]  Claude P. Champagne,et al.  The Freeze-Drying of Lactic Acid Bacteria. A Review , 1991 .

[10]  R. Fuller,et al.  Probiotics in man and animals. , 1989, The Journal of applied bacteriology.

[11]  T. Mitsuoka Recent Trends in Research on Intestinal Flora , 1982 .

[12]  S. Bingham,et al.  Starch intake and colorectal cancer risk: an international comparison. , 1994, British Journal of Cancer.

[13]  I. Brown,et al.  High amylose maize starch as a versatile prebiotic for use with probiotic bacteria , 1998 .

[14]  R. I. Dave,et al.  Ingredient supplementation effects on viability of probiotic bacteria in yogurt. , 1998, Journal of dairy science.

[15]  M. Warhurst,et al.  Fecal numbers of bifidobacteria are higher in pigs fed Bifidobacterium longum with a high amylose cornstarch than with a low amylose cornstarch. , 1997, The Journal of nutrition.

[16]  M. Blaut,et al.  Feeding resistant starch affects fecal and cecal microflora and short-chain fatty acids in rats. , 1997, Journal of animal science.

[17]  I. Rowland,et al.  Resistant starch modifies gut microflora and microbial metabolism in human flora‐associated rats inoculated with faeces from Italian and UK donors , 1999, Journal of applied microbiology.

[18]  P. Conway,et al.  The protective effects of high amylose maize (amylomaize) starch granules on the survival of Bifidobacterium spp. in the mouse intestinal tract , 1999, Journal of applied microbiology.

[19]  M. Roberfroid,et al.  Functional food properties of non-digestible oligosaccharides: a consensus report from the ENDO project (DGXII AIRII-CT94-1095) , 1999, British Journal of Nutrition.

[20]  V. Dillon Lactic acid Bacteria: Microbiology and Functional Aspects, 2nd edn. , 1998 .

[21]  G. Macfarlane,et al.  Role of intestinal bacteria in nutrient metabolism. , 1997, JPEN. Journal of parenteral and enteral nutrition.

[22]  J. Langhendries,et al.  Effect of a fermented infant formula containing viable bifidobacteria on the fecal flora composition and pH of healthy full-term infants. , 1995, Journal of pediatric gastroenterology and nutrition.

[23]  E. Schiffrin,et al.  Modulation of nonspecific mechanisms of defense by lactic acid bacteria: effective dose. , 1999, Journal of dairy science.

[24]  Ruth D. Davis,et al.  The biotechnology of lactic acid bacteria with emphasis on applications in food safety and human health , 1998 .

[25]  S. Salminen Lactic acid bacteria: microbiology and functional aspects. , 1998 .

[26]  H. Englyst,et al.  Classification and measurement of nutritionally important starch fractions. , 1992, European journal of clinical nutrition.

[27]  H. Haenel,et al.  Intestinal flora in health and disease. , 1975, Progress in food & nutrition science.

[28]  S. Shimamura,et al.  Bifidobacteria: research and development in Japan. , 1993 .

[29]  Y. Benno,et al.  Probiotics: how should they be defined? , 1999 .

[30]  F. Malcata,et al.  Growth enhancement of Bifidobacterium lactis Bo and Lactobacillus acidophilus Ki by milk hydrolyzates. , 1998, Journal of dairy science.

[31]  T. Mitsuoka,et al.  Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. , 1998, International journal of food microbiology.

[32]  T. Mattila-Sandholm,et al.  Adhesion of Bifidobacteria to Granular Starch and Its Implications in Probiotic Technologies , 2001, Applied and Environmental Microbiology.

[33]  R. Robinson,et al.  Acid production by bifidobacteria and yoghurt bacteria during fermentation and storage of milk , 1996 .

[34]  T. Mattila-Sandholm,et al.  Probiotic bacteria: safety, functional and technological properties. , 2000, Journal of biotechnology.

[35]  S. Salminen,et al.  Industrial use and production of lactic acid bacteria. , 1993 .

[36]  S. Ahrné,et al.  Survival of Lactobacillus plantarum DSM 9843 (299v), and effect on the short-chain fatty acid content of faeces after ingestion of a rose-hip drink with fermented oats. , 1998, International journal of food microbiology.

[37]  G. Macfarlane,et al.  Colonic microflora: nutrition and health. , 1997, Nutrition.

[38]  R. Satokari,et al.  Persistence of Colonization of Human Colonic Mucosa by a Probiotic Strain, Lactobacillus rhamnosusGG, after Oral Consumption , 1999, Applied and Environmental Microbiology.

[39]  G R Gibson,et al.  Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. , 1999, The American journal of clinical nutrition.

[40]  S. Salminen,et al.  Clinical Applications of Probiotic Bacteria , 1998 .

[41]  R. Sellars,et al.  Chapter 3 – Lactic Starter Culture Concentrates , 1979 .

[42]  A. Pfeifer,et al.  The development of functional foods: lessons from the gut. , 1999, Trends in biotechnology.

[43]  J. Johnson,et al.  Inactivation of lactic acid bacteria during spray drying , 1993 .